
01
Lung
Lung-derived matrix for pulmonary cell-culture models.
Lead program · In developmentPrivate preview
This website is currently available to invited reviewers.
Decellularized extracellular matrix, in the format your research needs.
Choose the tissueLung · Liver · Heart · Skeletal muscle · Skin · Kidney
Choose the chemistryNative · Methacrylated
Choose the formatPowder · Sponge · Scaffold · Pre-gel
Biomaterials
We develop tissue-derived ECM materials for cell culture.
Choose a tissue source, chemistry and format for your model.
Material formats
Dry ECM, pre-gel solutions and three-dimensional matrices.
Dry ECM for preparing your own formulations.
A cohesive, fibrous dry material that can be handled as a piece and rehydrated for use.
A structured, three-dimensional ECM format for cell culture.
ECM in solution for preparing a hydrogel.
Pre-gel adjusted to the target pH before gelation.
A hydrated ECM matrix, formed as a free-standing gel or cast in culture wells.
From formulation to culture
Cast a hydrogel directly in culture wells.
The product family
Healthy lung model
Lung-derived ECM for studying cells in a more compliant environment.
Fibrotic lung model
A higher-stiffness environment for lung-fibrosis research.
Liver-derived ECM
Myocardium-derived ECM
Skeletal muscle-derived ECM
Skin-derived ECM
Kidney-derived ECM
Tissue portfolio
Lung and liver lead development.

01
Lung-derived matrix for pulmonary cell-culture models.
Lead program · In development
02
Liver-derived matrix for hepatic cell-culture models.
Lead program · In development
03
Heart-muscle-derived matrix for cardiac cell-culture models.
In development
04
Skeletal-muscle-derived matrix for muscle cell-culture models.
In development
05
Skin-derived matrix for cutaneous cell-culture models.
In development
06
Kidney-derived matrix for renal cell-culture models.
In developmentThe portfolio is in development. Products are not yet available for sale.
Advanced in vitro models
First focus Pulmonary fibrosis
Our research program compares drug responses in 3D lung ECM models, studying matrix stiffness and human donor variation.
Your research question
Choose the compounds and the response to measure.
The TissueForge model
Study how matrix conditions and human donor variation shape drug responses in 3D lung-matrix models.
Evidence for the next decision
Compare responses across matrix conditions and donors to guide further testing.
Team
Co-founder & CEO
Mohd is a biomaterials scientist and bioengineer with more than a decade of research in cell biology, tissue-derived ECM and biofabrication. He develops engineered matrices and human cell models for laboratory research.
Co-founder & CTO
Neda is a biomedical engineer working on tissue engineering, biomaterial fabrication and advanced cell-culture models. Her work combines material formulation with multicellular tissue models, including engineered skin, and reproducible experimental workflows.
Development status
Next steps include product qualification, external research use and pilot studies for the pulmonary-fibrosis testing program.